Fertil Gynecol Androl

Image Credit:Fertil Gynecol Androl

Prenatal Screening Tests from the Perspective of Medical Ethics and Law: A Qualitative Research in Iran

Author(s):
Saeed BiroudianSaeed Biroudian1, Ali Soror EmamiAli Soror Emami2, Zohreh Kazempour KeleshteriZohreh Kazempour Keleshteri2, Kourosh DelpasandKourosh DelpasandKourosh Delpasand ORCID3,*
1Assistant Professor of Medical Ethics, Department of Medical Ethics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
2Razi Clinical Research Development Unit, Guilan University of Medical Sciences, Rasht,Iran
3Associate Professor of Medical Ethics, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran

Fertility, Gynecology and Andrology:Vol. 5, issue 1; e158613
Published online:Oct 29, 2025
Article type:Research Article
Received:Dec 10, 2024
Accepted:Oct 26, 2025
How to Cite:Biroudian S, Soror Emami A, Kazempour Keleshteri Z, Delpasand K. Prenatal Screening Tests from the Perspective of Medical Ethics and Law: A Qualitative Research in Iran.Fertil Gynecol Androl.2025;5(1):e158613.https://doi.org/10.5812/fga-158613.

Abstract

Background:

The advancement of new techniques in prenatal testing results in an increased amount of information that must be communicated to expectant mothers.

Objectives:

The present study aims to investigate prenatal screening tests from the perspective of medical ethics and law.

Methods:

In this qualitative study, individual semi-structured interviews were carried out in March and April 2023 in Guilan province, involving a total of seven participants (n = 7), including four gynecologists, one neonatologist, one genetics PhD, and one medical ethics PhD. All interviews were conducted face-to-face and led by two researchers with expertise in qualitative research.

Results:

The findings demonstrate a conflict between the concept of patient autonomy and the healthcare provider's responsibility to prioritize the health of both the mother and the fetus. Although prenatal screening provides significant medical advantages, such as early detection of genetic abnormalities, participants in this study expressed concerns regarding the practical, financial, psychological, and ethical difficulties in performing these tests successfully and efficiently.

Conclusions:

According to the results, medical professionals emphasize the necessity for a broader strategy that includes not just the medical and technological advances of prenatal testing but also wider ethical, legal, and social considerations.

1. Background

Prenatal screening tests are essential parts of modern obstetric care, providing critical data regarding fetal health and growth during pregnancy (1, 2). These tests aim to evaluate the likelihood of specific genetic and congenital disorders, enabling both expecting parents and healthcare professionals to make informed decisions (3, 4). The advancement of prenatal screening began in the 1970s with the maternal serum alpha-fetoprotein (AFP) test used to detect neural tube abnormalities. Since then, the field has considerably widened with various options such as ultrasonography, blood tests, and more recently, non-invasive prenatal testing (NIPT) that examines cell-free fetal DNA in maternal blood for detecting genetic mutations and disorders (5, 6). Despite the benefits, prenatal screening tests also raise important medical, ethical, and legal considerations (7, 8). The implications of test results can profoundly affect parental decision-making, including the choice to pursue further diagnostic testing or consider termination of pregnancy based on perceived risks. Consequently, debates on informed consent, the possible anxiety arising from unclear results, and the social effects of selective screening procedures are becoming increasingly important in the field of prenatal care (7, 9, 10).

2. Objectives

Given the aforementioned, the concept of prenatal screening tests is more complicated in Islamic nations like Iran, due to political, legal, cultural, and religious restrictions (11, 12). As these are not profoundly studied, in the present study, we aimed to examine prenatal screening tests from the perspective of medical ethics and law in a qualitative research study in Iran.

3. Methods

In this qualitative study, we carried out semi-structured interviews with gynecologists and professors of genetics and medical ethics, as well as a neonatal specialist in Rasht, Iran. For this study, we employed a qualitative research approach using explorative narrative interviews. The goal of this interview method was to gain a deep understanding of the interviewees' personal perspectives, experiences, and interpretations related to the research topic. The design of the interview questions and the identification of key themes were intended to elicit responses that are relevant to both the interview topic and the backgrounds of the interviewees. As a survey method, exploratory interviews offer a certain flexibility by allowing us to ask ad-hoc questions in order to clarify statements or to focus on particularly important issues. The criteria for inclusion in the study required participants to be willing to take part and provide informed consent, to have the ability to comprehend the questions, to be able to read and write, and to not have any diagnosed psychological disorders.

Individual semi-structured interviews were conducted in Guilan province during March and April 2023. Sampling and interviews continued until data saturation was achieved, resulting in a total of seven participants (n = 7), including four gynecologists, one neonatologist, one PhD in genetics, and one PhD in medical ethics. All interviews were conducted face-to-face. The sessions were led by two researchers who hold PhD degrees and possess expertise in the research topic and qualitative research methodologies. Interviews focused on four questions: (1) What are the challenges of screening? (2) What are the challenges of not doing screening? (3) Can the risks of screening be a reason not to do it? (4) Why are safe methods not used? To ensure validity, the study employed the Content Validity Index (CVI) and content validity ratio (CVR) for assessing content validity. Regarding the CVI, all questions across three sections demonstrated simplicity, clarity, and relevance scores exceeding 0.7, while the CVR for all questions was also above 0.7.

Data collection involved obtaining informed consent from participants and conducting interviews either in person or by telephone. The interviews, lasting an average of 30 minutes, focused on four central questions. Probing questions were used to further explore participants' insights. The interviews revealed new dimensions of the topic as the study progressed, allowing the interviewer to refine subsequent discussions. Qualitative data were analyzed using Granheim and Landman’s method (13) for conventional content analysis. Most interviews were recorded. The coding process in this qualitative study was carried out as follows: All interviews were carefully read multiple times to allow the researchers to become thoroughly familiar with the data. Meaning units relevant to the research objectives were extracted and identified. These meaning units were manually coded into initial codes and recorded in a coding table. Similar codes were grouped into conceptual clusters, and through a gradual categorization process, subcategories and eventually main categories were extracted. The coding and categorization process was conducted inductively and continued based on the repetition of concepts and data within the interviews until data saturation was reached. Finally, data analysis was performed independently by two researchers, and the results were compared and reviewed to increase the reliability of the findings.

Prior to the commencement of the study, no prior relationship had been established with the interviewees. At the start of each interview, the participants were provided with information about the research objectives and procedures, assured that their participation was voluntary, and informed about the measures taken to protect and archive the data collected during the interviews. Consent was also obtained regarding the publication of results in an anonymized format. Since the research questions did not specifically investigate the influence of individual characteristics of the interviewees, such as age, gender, career path, or professional background, on the research topic, no demographic data were gathered during the interviews. Data analysis was performed utilizing content analysis and thematic analysis techniques (14). Initially, the interviewees' responses were distilled into essential elements and statements. These elements were then manually coded, extracted, and organized into main topics and subtopics through clustering. The topics were developed inductively based on the interview content to identify significant and recurring themes, as well as variations in the responses.

4. Results

In this study, 10 people were arranged to conduct interviews, and three of them did not want to cooperate. Out of the 7 interviewees, 4 women were gynecologists, one man had a degree in neonatology, one woman had a doctorate in genetics, and one man had a doctorate in ethics. Table 1 shows an overview of the thematic focus of each individual's responses. These thematic focus points determine the structure of this section.

Table 1.Thematic Focus of the Responses in Each Section
ParticipantsThematic Focus of the Responses
Participant 1 a
What are the challenges of screening?Paying double fees – patients neglecting screening due to lack of awareness of the importance of doing it, despite the repeated recommendations of the doctor.
What are the challenges of not doing screening?Lack of knowledge about the genetic structure of the fetus, which can cause the failure to perform the required medical treatments – the birth of babies with genetic problems
Can the risks of screening be a reason not to do it?No, because the proportion of negative consequences of the screening procedure is much, much smaller than the injuries caused by the birth of children with genetic problems.
Why are safe methods not used?High cost and lack of suitable kits in the country
Participant 2 a
What are the challenges of screening?Creating stress for the result
What are the challenges of not doing screening?Until the end of pregnancy, stress is remained for the mother and the doctor – maintenance costs in case of birth defects.
Can the risks of screening be a reason not to do it?No, screening is much better than not screening.
Why are safe methods not used?Due to the high cost and the lack of insurance coverage, the cell free fetal DNA method is not used.
Participant 3 a
What are the challenges of screening?Since screening methods are not definitive, they must be confirmed with amniocentesis, and this procedure can cause pregnancy loss, bleeding, infection, and premature birth.
What are the challenges of not doing screening?It takes away the chance of early diagnosis of the anomaly and imposes a double cost for the treatment.
Can the risks of screening be a reason not to do it?No, screening is much better than not screening.
Why are safe methods not used?High cost and the need for confirmation with amniocentesis
Participant 4 a
What are the challenges of screening?Imposing a high cost on the society that needs government support – false positive answers, more stress and more expensive examinations are required.
What are the challenges of not doing screening?Failure to perform screening also results in the chance of birth of chromosomal abnormalities that impose a lot of financial and psychological costs on the family and society, which cannot be compared to the costs of screening, and prophylaxis and prevention of damage have been proven. It will have less cost and burden for the family, health system and society.
Can the risks of screening be a reason not to do it?No, abortion caused by amniocentesis is not significant in addition to the low probability compared to the benefits of this method.
Why are safe methods not used?It is used, today, in many cases, the cell free fetal DNA method has routinely replaced invasive methods such as amniocentesis.
Participant 5 b
What are the challenges of screening?High cost, mothers' lack of knowledge about gender issues, lack of full insurance coverage, limitation of screening centers
What are the challenges of not doing screening?In case of birth of a defective baby, heavy costs are incurred by the family and the government, and it has various economic, social and psychological consequences for the child's parents.
Can the risks of screening be a reason not to do it?In my opinion, its benefits are more than its disadvantages.
Why are safe methods not used?The necessary equipment is either not available in Iran, or has very high costs, or has more of a study role and has not yet been included in the country's guidelines and instructions.
Participant 6 c
What are the challenges of screening?Tests performed can give false positive results that indicate the presence of a problem in the fetus, when in fact it is not. This can lead to the anxiety of a false positive result and lead to more tests that are themselves dangerous, such as amniocentesis or ultrasound with curettage. Likewise, the accuracy of these tests can be limited.
What are the challenges of not doing screening?Missing early detection opportunities is a problem that happened recently and stuck in my mind. Pregnancy tests are important because of the diagnosis of most health problems of the pregnancy process. Without these tests, serious health events may not be detected until after the baby is born, causing delays in treatment and more serious consequences for the baby's health.
Can the risks of screening be a reason not to do it?In my opinion, it comes back to the parents. Humans have many differences, especially in psychological issues, one should not use the same prescription for everyone.
Why are safe methods not used?I don't know anything about the method.
Participant 7 d
What are the challenges of screening?High cost, non-acceptance of the truth by parents, non-acceptance of risk, difficulty of access
What are the challenges of not doing screening?Practically, not performing screening tests means accepting the possibility of any congenital defect for the fetus.
Can the risks of screening be a reason not to do it?Yes, the risks associated with fetal screening can be a reason not to perform it. But it should be noted that fetal examinations can provide important information about the health of the fetus to the doctor and the family, and it is up to them to decide whether they want to do these examinations or not.
Why are safe methods not used?The mentioned methods are not available everywhere and are very expensive.

a Gynecologists.

b Professors of genetics.

c Medical ethics.

d Neonatal specialist.

5. Discussion

The overlap of medical ethics and law regarding prenatal screening and pregnancy termination serves as a complex landscape, particularly in Iran, where cultural, religious, and legal frameworks profoundly impact decision-making processes (15, 16). This qualitative study aimed to explore the perspectives of healthcare professionals in Iran on the ethical and legal challenges associated with fetal testing. The findings demonstrate a conflict between the concept of patient autonomy and the healthcare provider's responsibility to prioritize the health of both the mother and the fetus. Although prenatal screening provides significant medical advantages, such as early detection of genetic abnormalities, participants in this study expressed concerns regarding the practical, financial, psychological, and ethical difficulties in performing these tests successfully and efficiently. As mentioned, it can be complex to balance patient autonomy and medical benefit in prenatal care decision-making. The concept of autonomy emphasizes the necessity of enabling patients to make informed decisions about their treatment; nevertheless, this is sometimes confounded by the complicated nature of fetal screening (11, 17).

One of the primary challenges discussed by participants was the financial burden of prenatal tests. High costs and limited insurance coverage were repeatedly cited as barriers to using advanced screening methods such as NIPT (18-20). These financial barriers can lead to disparities in access to essential prenatal care, with lower-income families potentially forgoing screening altogether due to its expense. This inequality in access raises ethical concerns about the fairness and justice of healthcare provision, especially in a system where screening could prevent long-term financial and emotional costs associated with caring for a child with a congenital disability. Addressing these financial obstacles requires comprehensive policy changes focused on improving insurance coverage and reducing personal costs for vital prenatal tests (21-23).

The psychological impacts of prenatal screening on expectant parents are a notable concern, particularly in relation to false-positive outcomes (24-26). Research demonstrates that women undergoing prenatal diagnostic procedures commonly experience higher levels of anxiety and psychological distress, which may be underestimated in clinical settings. Studies indicate that women who undergo invasive tests report significantly greater anxiety levels compared to those who have not yet been screened or who have received reassuring results from anomaly scans, influenced by factors such as uncertainty from healthcare providers, financial concerns, and prior adverse experiences (24-28).

This study has some limitations. The qualitative method used for the research, while beneficial for in-depth exploration of the views of professionals, unavoidably restricts the generalizability of the findings. The limited sample size may not comprehensively represent the general population of healthcare professionals. The involvement of specialists from particular domains offers a concentrated yet restricted perspective on the issue. Further studies with larger sample sizes, involving a wide variety of healthcare providers and also parents, are needed.

5.1. Conclusions

This research highlights the complex interaction among ethical, psychological, and practical issues in prenatal screening in Iran. Medical professionals emphasize the necessity for a broader strategy that includes not just the medical and technological aspects of prenatal testing but also wider ethical, legal, and social considerations.

Footnotes

References

  • 1.
    Alkhatib AJ, Alkhatib IA, Alkhatib MA, Alkhatib NA. The Critical Role of Prenatal Care: Promoting Optimal Health for Expectant Mothers and Their Infants in the Modern Era. PSM Veterinary Res. 2023;8(2):13-9.
  • 2.
    Wilson RD. Every mother and every fetus matters: A positive pregnancy test = multiple offerings of reproductive risk screening for personal, family, and specific obstetrical-fetal conditions. Int J Gynaecol Obstet. 2022;159(1):65-78. [PubMed ID: 34927726]. https://doi.org/10.1002/ijgo.14074.
  • 3.
    Jacobsson B, Requejo JH, Dey T, Lavin T, Mannah MT, Menon R, et al. Women's health and maternal care services: seizing missed opportunities to prevent and manage preterm birth. Reprod Health. 2025;22(Suppl 2):109. [PubMed ID: 40556011]. [PubMed Central ID: PMC12186347]. https://doi.org/10.1186/s12978-025-02034-w.
  • 4.
    Oyelese Y, Schioppo D, O'Brien B. Prenatal Screening and Diagnosis: Time for a Paradigm Shift. Am J Perinatol. 2025;42(4):538-45. [PubMed ID: 38657662]. https://doi.org/10.1055/a-2312-8824.
  • 5.
    Gallo P. Dilemas éticos del diagnóstico genético prenatal no invasivo, utilizando la tecnología de ADN fetal libre en células: una valoración de los primeros diez años, desde su introducción en la práctica médica. Medicina y Ética. 2022;33(2):323-56. https://doi.org/10.36105/mye.2022v33n2.01.
  • 6.
    Vanstone M, Cernat A, Nisker J, Schwartz L. Women's perspectives on the ethical implications of non-invasive prenatal testing: a qualitative analysis to inform health policy decisions. BMC Med Ethics. 2018;19(1):27. [PubMed ID: 29661182]. [PubMed Central ID: PMC5902938]. https://doi.org/10.1186/s12910-018-0267-4.
  • 7.
    Kaye DK. Addressing ethical issues related to prenatal diagnostic procedures. Matern Health Neonatol Perinatol. 2023;9(1):1. [PubMed ID: 36737803]. [PubMed Central ID: PMC9896777]. https://doi.org/10.1186/s40748-023-00146-4.
  • 8.
    Gallois H, Ravitsky V, Roy MC, Laberge AM. Defining ethical criteria to guide the expanded use of Noninvasive Prenatal Screening (NIPS): Lessons about severity from preimplantation genetic testing. Eur J Hum Genet. 2025;33(2):167-75. [PubMed ID: 39462080]. [PubMed Central ID: PMC11840150]. https://doi.org/10.1038/s41431-024-01714-8.
  • 9.
    Britt DW, Risinger ST, Miller V, Mans MK, Krivchenia EL, Evans MI. Determinants of parental decisions after the prenatal diagnosis of down syndrome: bringing in context. Am J Med Genet. 2000;93(5):410-6. [PubMed ID: 10951466].
  • 10.
    Schechtman KB, Gray DL, Baty JD, Rothman SM. Decision-making for termination of pregnancies with fetal anomalies: analysis of 53,000 pregnancies. Obstet Gynecol. 2002;99(2):216-22. [PubMed ID: 11814500]. https://doi.org/10.1016/s0029-7844(01)01673-8.
  • 11.
    Saniei M, Mehr EJ, Shahraz S, Zahedi LN, Rad AM, Sayar S, et al. Prenatal screening and counseling in Iran and ethical dilemmas. Community Genet. 2008;11(5):267-72. [PubMed ID: 18493124]. https://doi.org/10.1159/000121397.
  • 12.
    Asadisarvestani K, Sobotka T. A pronatalist turn in population policies in Iran and its likely adverse impacts on reproductive rights, health and inequality: a critical narrative review. Sex Reprod Health Matters. 2023;31(1):2257075. [PubMed ID: 37830775]. [PubMed Central ID: PMC10578100]. https://doi.org/10.1080/26410397.2023.2257075.
  • 13.
    Graneheim UH, Lundman B. Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Nurse Educ Today. 2004;24(2):105-12. [PubMed ID: 14769454]. https://doi.org/10.1016/j.nedt.2003.10.001.
  • 14.
    Orzechowski M, Timmermann C, Woniak K, Kosenko O, Mikirtichan GL, Lichtshangof AZ, et al. Access to Prenatal Testing and Ethically Informed Counselling in Germany, Poland and Russia. J Pers Med. 2021;11(9). [PubMed ID: 34575714]. [PubMed Central ID: PMC8469421]. https://doi.org/10.3390/jpm11090937.
  • 15.
    Ahaddour C. Ethical Issues at the Beginning of Human Life: Towards a Contextualized Islamic Understanding of Prenatal Diagnosis and Termination of Pregnancy. Louvain studies. 2022;44(4):319-39.
  • 16.
    Ahmed S. Abortion and Women: Intersects of Religion, Law, and Society - A Perspective From Muslim Majority Countries. In: Pucelj M, Matusiak-Frącczak M, editors. Global Perspectives on Reproductive Rights and Policies. Hershey, PA, USA: IGI Global Scientific Publishing; 2025. p. 123-56. https://doi.org/10.4018/979-8-3693-7837-3.ch005.
  • 17.
    Strong C. Fetal anomalies: ethical and legal considerations in screening, detection, and management. Clin Perinatol. 2003;30(1):113-26. [PubMed ID: 12696790]. https://doi.org/10.1016/s0095-5108(02)00083-0.
  • 18.
    Benoy ME, Iruretagoyena JI, Birkeland LE, Petty EM. The impact of insurance on equitable access to non-invasive prenatal screening (NIPT): private insurance may not pay. J Community Genet. 2021;12(1):185-97. [PubMed ID: 33404996]. [PubMed Central ID: PMC7846657]. https://doi.org/10.1007/s12687-020-00498-w.
  • 19.
    Jayashankar SS, Nasaruddin ML, Hassan MF, Dasrilsyah RA, Shafiee MN, Ismail NAS, et al. Non-Invasive Prenatal Testing (NIPT): Reliability, Challenges, and Future Directions. Diagnostics (Basel). 2023;13(15). [PubMed ID: 37568933]. [PubMed Central ID: PMC10417786]. https://doi.org/10.3390/diagnostics13152570.
  • 20.
    Kater-Kuipers A, Bunnik EM, de Beaufort ID, Galjaard RJH. Limits to the scope of non-invasive prenatal testing (NIPT): an analysis of the international ethical framework for prenatal screening and an interview study with Dutch professionals. BMC Pregnancy Childbirth. 2018;18(1):409. [PubMed ID: 30340550]. [PubMed Central ID: PMC6194707]. https://doi.org/10.1186/s12884-018-2050-4.
  • 21.
    de Jong A, Dondorp WJ, de Die-Smulders CE, Frints SG, de Wert GM. Non-invasive prenatal testing: ethical issues explored. Eur J Hum Genet. 2010;18(3):272-7. [PubMed ID: 19953123]. [PubMed Central ID: PMC2987207]. https://doi.org/10.1038/ejhg.2009.203.
  • 22.
    Sparks TN, Caughey AB. How should costs and cost-effectiveness be considered in prenatal genetic testing? Semin Perinatol. 2018;42(5):275-82. [PubMed ID: 30173949]. [PubMed Central ID: PMC6204084]. https://doi.org/10.1053/j.semperi.2018.07.003.
  • 23.
    Wang S, Liu K, Yang H, Ma J. A Cost-Effectiveness Analysis of Screening Strategies Involving Non-Invasive Prenatal Testing for Trisomy 21. Front Public Health. 2022;10:870543. [PubMed ID: 35712262]. [PubMed Central ID: PMC9194099]. https://doi.org/10.3389/fpubh.2022.870543.
  • 24.
    Al Muteri T. Psychological Impact of False-Positive Results in Obstetric Screening: A Systematic Review. Clin Experim Obstetrics Gynecol. 2025;52(5). https://doi.org/10.31083/ceog26696.
  • 25.
    Chudleigh J, Holder P. Psychosocial Impact of False-Positive Newborn Screening Results: A Scoping Review. Children (Basel). 2024;11(5). [PubMed ID: 38790502]. [PubMed Central ID: PMC11120117]. https://doi.org/10.3390/children11050507.
  • 26.
    Mohammadi T, Zhang W, Anis AH. The impact of psychological distance on preferences for prenatal screening and diagnosis for chromosomal abnormalities: A hierarchical Bayes analysis of a discrete choice experiment. PLoS One. 2025;20(5). e0324370. [PubMed ID: 40408540]. [PubMed Central ID: PMC12101744]. https://doi.org/10.1371/journal.pone.0324370.
  • 27.
    Allison SJ, Stafford J, Anumba DO. The effect of stress and anxiety associated with maternal prenatal diagnosis on feto-maternal attachment. BMC Womens Health. 2011;11:33. [PubMed ID: 21749702]. [PubMed Central ID: PMC3148201]. https://doi.org/10.1186/1472-6874-11-33.
  • 28.
    Mirtabar SM, Pahlavan Z, Aligoltabar S, Barat S, Nasiri-Amiri F, Nikpour M, et al. Women's worries about prenatal screening tests suspected of fetal anomalies: a qualitative study. BMC Womens Health. 2023;23(1):66. [PubMed ID: 36782219]. [PubMed Central ID: PMC9926685]. https://doi.org/10.1186/s12905-023-02211-8.

Crossmark
Crossmark
Checking
Share on
Cited by
Metrics

Purchasing Reprints

  • Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here (   https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.
Search Relations

Author(s):

Related Articles